regulator of G-protein signaling 13 | R4 family | IUPHAR Guide to IMMUNOPHARMACOLOGY

Top ▲

regulator of G-protein signaling 13

  Target has curated data in GtoImmuPdb

Target id: 2805

Nomenclature: regulator of G-protein signaling 13

Abbreviated Name: RGS13

Family: R4 family

Annotation status:  image of a grey circle Awaiting annotation/under development. Please contact us if you can help with annotation.  » Email us

Gene and Protein Information
Species TM AA Chromosomal Location Gene Symbol Gene Name Reference
Human - 159 1q31.2 RGS13 regulator of G protein signaling 13 9
Mouse - 158 1 F Rgs13 regulator of G-protein signaling 13 14
Rat - 158 13q21 Rgs13 regulator of G-protein signaling 13
Database Links
Ensembl Gene
Entrez Gene
Human Protein Atlas
RefSeq Nucleotide
RefSeq Protein
Associated Proteins
G Proteins
Name References
Interacting Proteins
Name Effect References
phosphoinositide-3-kinase regulatory subunit 2 Inhibits PI3 kinase signaling. 2
phosphoCREB Inhibits CREB transcription. 17
Immunopharmacology Comments
RGS13 inhibits CXCL12- and CXCL13-induced MAPK activation, and chemotaxis [14]; in contrast RGS13 knockdown enhances CXCL12 and CXCL13 responsiveness [5].
Cell Type Associations
Immuno Cell Type:  B cells
Cell Ontology Term:   B cell (CL:0000236)
References:  1-2
Immuno Cell Type:  Dendritic cells
Cell Ontology Term:   dendritic cell (CL:0000451)
Comment:  NB mouse dendritic cells.
References:  14
Immuno Cell Type:  Mast cells
Cell Ontology Term:   mast cell (CL:0000097)
References:  1-2
Tissue Distribution
Tonsil, thymus, lung, lymph node, spleen, lymph node and lymphocytes.
Species:  Human
Technique:  RT-PCR.
References:  7,9,11
EBV-infected B cells.
Species:  Human
Technique:  Microarray analysis.
References:  3
B cells, mast cells.
Species:  Human
Technique:  Western blot.
References:  1-2,5,10
Spleen, stomach, small intestine, thymus.
Species:  Mouse
Technique:  Northen blot.
References:  14
Dendritic cells.
Species:  Mouse
Technique:  RT-PCR.
References:  13
Species:  Rat
Technique:  In situ hybridisation.
References:  4
Functional Assays
RGS13 blunts carbachol-induced MAPK activation in cells expressing the muscarinic M2 receptor.
Species:  Human
Tissue:  293T and A9L cells expressing muscarinic receptor.
Response measured:  Decreased MAPK phosphorylation (as ERK phosphorylation level).
References:  9
RGS13 inhibits CXCL12- and CXCL13-induced MAPK activation, and chemotaxis.
Species:  Mouse
Tissue:  COS or CHO cells expressing CXCR4 or CXCR5 receptors and RGS13.
Response measured:  Decreased MAPK phosphorylation (as ERK phosphorylation level), inhibition of chemotaxis.
References:  14
Knockdown of RGS13 in a Burkitt's lymphoma cell line enhances responsiveness to the chemokines CXCL12 and CXCL13 and increases chemoattraction.
Species:  Human
Tissue:  HS-Sultan B cell lymphoma cell line.
Response measured:  Increased Ca2+ mobilization, polarization.
References:  5
Knockdown of RGS13 in mast cells enhances responsiveness to several natural GPCR ligands and increases chemotaxis.
Species:  Human
Tissue:  Mast cells.
Response measured:  Increased Ca2+ molilization, Akt phosphorylation and chemotaxis.
References:  1
Physiological Functions
RGS13 suppresses IgE-mediated mast cell degranulation and systemic anaphylaxis.
Species:  Mouse
Tissue:  Mast cells, multiorgan effects.
References:  2
RGS13 inhibits early antibody responses, plasma cell expansion, and germinal center formation in lymphoid organs following immunization.
Species:  Mouse
Tissue:  Lymph node.
References:  6
RGS13 promotes autoantibody formation in autoimmune-prone mice.
Species:  Mouse
Tissue:  Lymph node.
References:  16
Xenobiotics Influencing Gene Expression
Doxorubicin reduces RGS13 expression in mast cells.
Species:  Human
Tissue:  LAD2 human mast cell line.
Technique:  Quantitative PCR, immunoblotting.
References:  8
Clinically-Relevant Mutations and Pathophysiology
Disease:  Mantle cell lymphoma
Disease Ontology: DOID:0050746
Orphanet: ORPHA52416
References:  7
Disease:  Non-allergic (intrinsic) asthma
Description: Although characteristic symptoms are the same as for allergic asthma, non-allergic asthma is triggered by factors not related to allergies (e.g. anxiety, stress, exercise, cold air, dry air, hyperventilation, smoke, viruses or other irritants) and the immune system is not involved in the reaction.
References:  12
Disease:  Squamous cell carcinoma, head and neck
Synonyms: HNSCC
OMIM: 275355
Orphanet: ORPHA67037
References:  15


Show »

1. Bansal G, DiVietro JA, Kuehn HS, Rao S, Nocka KH, Gilfillan AM, Druey KM. (2008) RGS13 controls g protein-coupled receptor-evoked responses of human mast cells. J. Immunol., 181 (11): 7882-90. [PMID:19017978]

2. Bansal G, Xie Z, Rao S, Nocka KH, Druey KM. (2008) Suppression of immunoglobulin E-mediated allergic responses by regulator of G protein signaling 13. Nat. Immunol., 9 (1): 73-80. [PMID:18026105]

3. Cahir-McFarland ED, Carter K, Rosenwald A, Giltnane JM, Henrickson SE, Staudt LM, Kieff E. (2004) Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells. J. Virol., 78 (8): 4108-19. [PMID:15047827]

4. Grafstein-Dunn E, Young KH, Cockett MI, Khawaja XZ. (2001) Regional distribution of regulators of G-protein signaling (RGS) 1, 2, 13, 14, 16, and GAIP messenger ribonucleic acids by in situ hybridization in rat brain. Brain Res. Mol. Brain Res., 88 (1-2): 113-23. [PMID:11295237]

5. Han JI, Huang NN, Kim DU, Kehrl JH. (2006) RGS1 and RGS13 mRNA silencing in a human B lymphoma line enhances responsiveness to chemoattractants and impairs desensitization. J. Leukoc. Biol., 79 (6): 1357-68. [PMID:16565322]

6. Hwang IY, Hwang KS, Park C, Harrison KA, Kehrl JH. (2013) Rgs13 constrains early B cell responses and limits germinal center sizes. PLoS ONE, 8 (3): e60139. [PMID:23533672]

7. Islam TC, Asplund AC, Lindvall JM, Nygren L, Liden J, Kimby E, Christensson B, Smith CI, Sander B. (2003) High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma. Leukemia, 17 (9): 1880-90. [PMID:12970790]

8. Iwaki S, Lu Y, Xie Z, Druey KM. (2011) p53 negatively regulates RGS13 protein expression in immune cells. J. Biol. Chem., 286 (25): 22219-26. [PMID:21531726]

9. Johnson EN, Druey KM. (2002) Functional characterization of the G protein regulator RGS13. J. Biol. Chem., 277 (19): 16768-74. [PMID:11875076]

10. Kauppila A, Mäkilä UM, Mäkäräinen L, Puolakka J, Seppälä A. (1986) Tiaprofenic acid in the treatment of primary dysmenorrhoea. Eur. J. Obstet. Gynecol. Reprod. Biol., 22 (5-6): 359-63. [PMID:3533672]

11. Larminie C, Murdock P, Walhin JP, Duckworth M, Blumer KJ, Scheideler MA, Garnier M. (2004) Selective expression of regulators of G-protein signaling (RGS) in the human central nervous system. Brain Res. Mol. Brain Res., 122 (1): 24-34. [PMID:14992813]

12. Raedler D, Ballenberger N, Klucker E, Böck A, Otto R, Prazeres da Costa O, Holst O, Illig T, Buch T, von Mutius E et al.. (2015) Identification of novel immune phenotypes for allergic and nonallergic childhood asthma. J. Allergy Clin. Immunol., 135 (1): 81-91. [PMID:25226851]

13. Shi GX, Harrison K, Han SB, Moratz C, Kehrl JH. (2004) Toll-like receptor signaling alters the expression of regulator of G protein signaling proteins in dendritic cells: implications for G protein-coupled receptor signaling. J. Immunol., 172 (9): 5175-84. [PMID:15100254]

14. Shi GX, Harrison K, Wilson GL, Moratz C, Kehrl JH. (2002) RGS13 regulates germinal center B lymphocytes responsiveness to CXC chemokine ligand (CXCL)12 and CXCL13. J. Immunol., 169 (5): 2507-15. [PMID:12193720]

15. Wang J, Lippman SM, Lee JJ, Yang H, Khuri FR, Kim E, Lin J, Chang DW, Lotan R, Hong WK et al.. (2010) Genetic variations in regulator of G-protein signaling genes as susceptibility loci for second primary tumor/recurrence in head and neck squamous cell carcinoma. Carcinogenesis, 31 (10): 1755-61. [PMID:20627871]

16. Wang JH, New JS, Xie S, Yang P, Wu Q, Li J, Luo B, Ding Y, Druey KM, Hsu HC et al.. (2013) Extension of the germinal center stage of B cell development promotes autoantibodies in BXD2 mice. Arthritis Rheum., 65 (10): 2703-12. [PMID:23818250]

17. Xie Z, Geiger TR, Johnson EN, Nyborg JK, Druey KM. (2008) RGS13 acts as a nuclear repressor of CREB. Mol. Cell, 31 (5): 660-70. [PMID:18775326]


Show »

How to cite this page

Select citation format: